Logo image
Sign in
A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265)
Journal article   Peer reviewed

A phase 2 study of live-attenuated listeria monocytogenes cancer immunotherapy (ADXS11-001) in the treatment of persistent or recurrent cancer of the cervix (GOG-0265)

Warner King Huh, William E. Brady, Kathleen N. Moore, Heather A. Lankes, Bradley J. Monk, Carol Aghajanian, Don S. Dizon, Deborah K Armstrong, Premal H. Thaker and Paula M. Fracasso
Journal of clinical oncology, Vol.32(15_suppl), pp.TPS5617-TPS5617
05/20/2014

Abstract

Abstract only

Metrics

6 Record Views

Details